Biodesix, Inc. (BDSX)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$7.85
-7.15%
Mkt Cap $154.34M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$35.00
Range $32.00 – $38.00
Implied Upside
+345.9%
Consensus $35.00 vs current $7.85